Phagestack is developing a data-driven platform that allows antimicrobial agents to be developed specifically against certain harmful bacteria.
Phagestack has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Pulheim, Germany; active in Healthtech. Data as of 10 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-10 | Other | — |
| NRW.BANK |
| View deal → |
